EXPRESS PROTECT MULTI AKTIENANLEIHE - ROCHE GS/SWISS RE/ZURICH INSURANCE/NOVARTIS N Share Price

Certificat

DE000VV36MP4

Market Closed - Börse Stuttgart 07:43:50 10/05/2024 BST
99.55 EUR +0.88% Intraday chart for EXPRESS PROTECT MULTI AKTIENANLEIHE - ROCHE GS/SWISS RE/ZURICH INSURANCE/NOVARTIS N
Current month+1.41%
1 month+2.78%
Date Price Change Volume
10/05/24 99.55 +0.88% 0
09/05/24 98.68 +0.41% 0
08/05/24 98.28 +0.54% 0
07/05/24 97.75 +0.73% 0
06/05/24 97.04 -0.31% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 07:43 am

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VV36MP
ISINDE000VV36MP4
Date issued 25/07/2022
Strike 327.9 CHF
Maturity 25/07/2024 (76 Days)
Parity 0.33 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 104.1
Lowest since issue 93.71

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus